Provincial drug coverage through programs like Ontarios OHIP+ or British Columbias PharmaCare will eventually factor in once Retatrutide receives formal approval, but those pathways are likely 2+ years away
Program Includes: Supervised Monthly Check-ins with Nurse Practitioner Prescription Sent to Your Preferred Pharmacy (Discount cards available) Regular Weigh-ins and Medication Adjustments as needed Phentermine is not suitable for patients with heart disease, high blood pressure, glaucoma, overactive thyroid, or women who are pregnant, breastfeeding, or may become pregnant
One such option is Mounjaro (generic name: tirzepatide), a prescription medication that has shown remarkable results in helping individuals lose weight, especially those who are overweight or have obesity
Starting each meal with your protein sourcebefore adding vegetables and carbohydrateshelps you get the most important nutrient in before you feel full

Gastric Emptying Modulation GLP2 transiently delays gastric emptying, similar to selective GLP-1 receptor agonists: Slowed rate of nutrient absorption from the gastrointestinal tract Reduced postprandial glucose excursions Effect is most pronounced after initial doses and diminishes with continued treatment Contributes to improved glycemic control through multiple complementary mechanisms Central Nervous System Effects Appetite Regulation Both GIP and GLP-1 receptors are expressed in brain regions controlling appetite and food intake: Reduced food intake and appetite through central nervous system receptor activation Promotion of satiety signals leading to decreased caloric consumption Potential modulation of reward-related feeding behaviors Weight loss effects that appear mediated through both homeostatic and hedonic feeding pathways Clinical trials have demonstrated substantial weight reduction, with participants experiencing decreased appetite as a commonly reported effect of GLP2 treatment
